Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Abcam is a supplier of antibodies, assays and test kits for both research and clinical uses. Key to the...
— Brown Capital Management International All Company Fund
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Abcam plc
The manager discusses shareholder activism at Abcam that led management to launch a full strategic review of alternatives, including a potential sale. The ongoing governance...
The company faced operational and financial setbacks due to temporary disruptions from a major ERP software migration and pandemic lockdowns in China. The manager remains...
More institutional theses from Brown Capital Management International All Company Fund
The manager discusses shareholder activism at Abcam that led management to launch a full strategic review of alternatives, including a potential sale. The ongoing governance...
The manager is highly positive on RELX's subscription-heavy model and its proactive adoption of generative AI through Lexis+ AI. By training large...
The manager initiated a new position in the company to capture the large structural opportunity in advanced driver assisted systems and autonomous driving. Despite showing short-term...